Scientists are testing drugs to PREVENT Covid-19

by

Scientists Britain is testing a new one drug this could make those to whom they were exposed coronavirus does not develop the disease. The drug promises a protection which could play a vital role in reducing the impact of the virus worldwide.

According to the British newspaper The Guardian, antibody therapy could provide immediate immunity against the disease and can be administered as an emergency medicine and could help contain new outbreaks. Czech in The Truth News information.

Prevent covid-19.

This would be the first drug to prevent covid-19. photo: independent

YOU MAY WANT TO READ: COVID-19: People can be immune to the common flu

Coronavirus drug

The drug was developed by University College London Hospitals NHS (UCLH) and AstraZeneca, the same pharmaceutical company that, together with Oxford University, developed one of the coronavirus vaccines.

The new drug was developed based on a combination of long-acting antibodies known as AZD7442. Instead of antibodies produced by the body, AZD7442 uses monoclonal antibodies that were created in a laboratory.

Catherine Houlihan, the virologist who conducts the drug studies, told The Guardian that so far they have injected 10 participants, including staff, students and others, who have been exposed to the virus at home into a care unit. medical or student residences.

drug promises immediate protection that could play a vital role in reducing the impact of the virus worldwide, until all people were immunized.

The advantage of this medicine is that it gives you immediate antibodies.

Medicine, covid-19.

This medicine could prevent covid-19. photo: health consultants

Houlihan recalled that vaccines do not provide complete immunity until one month after administration.

The team responsible for developing the new drug hopes the study will show that antibodies can protect against COVID-19 for six to 12 months.

YOU MAY BE INTERESTED: The Pfizer and BioNTech COVID-19 vaccine uses state-of-the-art technology!

Available in March

If all goes well, the drug could be available in the UK from March to April if it is approved by health regulators after reviewing evidence of its functioning.

The new strain of COVID-19 continues to spread around the world. Follow us on Google News and find out all the details.




.Source